Biotech

All Articles

Galapagos stops CAR-T cell therapy hearing over Parkinsonism scenario

.Galapagos has stopped application in a trial of a BCMA-directed CAR-T cell therapy, pushing the bra...

James Wilson leaving Penn to launch two new biotechs

.After more than three decades, genetics therapy pioneer James Wilson M.D., Ph.D., is leaving behind...

3 biotechs try to defeat the summer months warmth by shedding staff

.As biotechs attempt to switch a new webpage in August, a minimum of three companies have shed perso...

venBio lifts $528M for 5th lifestyle scientific researches VC fund

.Veteran financial backing company venBio has lifted one more half a billion dollars to invest in bi...

Otsuka spends $800M for Jnana and its own clinical-stage PKU medication

.Otsuka Drug has picked up Boston-based Jnana Rehabs for $800 thousand so the Oriental biotech may r...

FibroGen lays off 75% people staff as property fails 2 more trials

.FibroGen is actually substantially reorganizing its business, giving up 75% of its own U.S. personn...

Tracon unwind weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has determined to wind down operations full weeks after an injectable immune...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on fallen short epilepsy medication, touts FDA operate

.We presently know that Takeda is actually wishing to discover a road to the FDA for epilepsy medici...

VBI Vaccines files for personal bankruptcy, finds asset purchase

.Immunology biotech VBI Vaccines is drifting hazardously near the climax, along with strategies to d...